VIVO - Meridian Bioscience EPS beats by $0.03 beats on revenue
Meridian Bioscience (NASDAQ:VIVO): Q4 Non-GAAP EPS of $0.23 beats by $0.03; GAAP EPS of $0.15 misses by $0.04. Revenue of $76.2M (+18.8% Y/Y) beats by $7.8M. Shares +0.78% PM. Press Release
For further details see:
Meridian Bioscience EPS beats by $0.03, beats on revenue